Ardelyx (ARDX) Shareholder Opaleye Management Lifted Its Stake by $1.20 Million as Share Price Declined; Intuitive Surgical (ISRG) Holder Fukoku Mutual Life Insurance Company Has Raised Position by $337,990

May 23, 2018 - By Dolores Ford

Intuitive Surgical, Inc. (NASDAQ:ISRG) Logo

James A. Silverman increased its stake in Ardelyx (ARDX) by 28.57% based on its latest 2017Q4 regulatory filing with the SEC. Opaleye Management Inc bought 200,000 shares as the company’s stock declined 23.36% with the market. The hedge fund run by James A. Silverman held 900,000 shares of the health care company at the end of 2017Q4, valued at $5.94M, up from 700,000 at the end of the previous reported quarter. Opaleye Management Inc who had been investing in Ardelyx for a number of months, seems to be bullish on the $216.60 million market cap company. The stock decreased 19.47% or $1.1 during the last trading session, reaching $4.55. About 2.69M shares traded or 725.36% up from the average. Ardelyx, Inc. (NASDAQ:ARDX) has declined 60.67% since May 23, 2017 and is downtrending. It has underperformed by 72.22% the S&P500.

Fukoku Mutual Life Insurance Company increased its stake in Intuitive Surgical Inc (ISRG) by 200% based on its latest 2017Q4 regulatory filing with the SEC. Fukoku Mutual Life Insurance Company bought 926 shares as the company’s stock rose 11.58% while stock markets declined. The institutional investor held 1,389 shares of the health care company at the end of 2017Q4, valued at $507,000, up from 463 at the end of the previous reported quarter. Fukoku Mutual Life Insurance Company who had been investing in Intuitive Surgical Inc for a number of months, seems to be bullish on the $51.51 billion market cap company. The stock decreased 1.89% or $8.77 during the last trading session, reaching $454.61. About 566,601 shares traded. Intuitive Surgical, Inc. (NASDAQ:ISRG) has risen 58.43% since May 23, 2017 and is uptrending. It has outperformed by 46.88% the S&P500.

Among 7 analysts covering Ardelyx Inc (NASDAQ:ARDX), 7 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Ardelyx Inc had 16 analyst reports since August 18, 2015 according to SRatingsIntel. Citigroup maintained Ardelyx, Inc. (NASDAQ:ARDX) rating on Friday, October 13. Citigroup has “Buy” rating and $19 target. The stock of Ardelyx, Inc. (NASDAQ:ARDX) has “Buy” rating given on Friday, March 16 by Cantor Fitzgerald. The rating was maintained by Cantor Fitzgerald with “Buy” on Wednesday, August 9. The rating was maintained by Wedbush on Thursday, October 12 with “Buy”. The rating was maintained by Cantor Fitzgerald on Thursday, October 12 with “Overweight”. The company was maintained on Wednesday, March 9 by JMP Securities. Cantor Fitzgerald maintained it with “Buy” rating and $1200 target in Wednesday, May 31 report. The company was maintained on Monday, August 28 by Cantor Fitzgerald. On Wednesday, August 10 the stock rating was maintained by Citigroup with “Buy”. BTIG Research initiated it with “Buy” rating and $33 target in Tuesday, September 22 report.

More notable recent Ardelyx, Inc. (NASDAQ:ARDX) news were published by: Benzinga.com which released: “Benzinga’s Daily Biotech Pulse: Melinta, Ardelyx Pull Back On Offerings, Insys Awaits FDA Verdict” on May 22, 2018, also Seekingalpha.com with their article: “Ardelyx Looks Cheap But Not Without Risk” published on May 17, 2018, Benzinga.com published: “38 Biggest Movers From Yesterday” on May 23, 2018. More interesting news about Ardelyx, Inc. (NASDAQ:ARDX) were released by: Nasdaq.com and their article: “Here’s Why Tiny Biotech Ardelyx Saw a Big Decline Today” published on May 22, 2018 as well as Streetinsider.com‘s news article titled: “Ardelyx (ARDX) Commences $50M Offering of Common Stock” with publication date: May 21, 2018.

More notable recent Intuitive Surgical, Inc. (NASDAQ:ISRG) news were published by: Seekingalpha.com which released: “Intuitive Surgical At The Cutting Edge” on May 13, 2018, also Investorplace.com with their article: “Does Intuitive Surgical, Inc. Have Any More Room to Run?” published on May 11, 2018, Nasdaq.com published: “Carve Through Weakness in Mazor Robotics Ltd. Stock With Surgical Precision” on May 14, 2018. More interesting news about Intuitive Surgical, Inc. (NASDAQ:ISRG) were released by: Nasdaq.com and their article: “New Study Shows Robotic-Assisted Surgery Benefits for Inguinal Hernia Repair” published on May 03, 2018 as well as Seekingalpha.com‘s news article titled: “Earnings Season’s Biggest Winners And Losers… So Far” with publication date: April 26, 2018.

Since January 30, 2018, it had 0 insider purchases, and 24 insider sales for $117.80 million activity. GUTHART GARY S also sold $16.38M worth of Intuitive Surgical, Inc. (NASDAQ:ISRG) on Monday, April 30. $123,260 worth of Intuitive Surgical, Inc. (NASDAQ:ISRG) shares were sold by SMITH LONNIE M. The insider RUBASH MARK J sold 1,000 shares worth $430,000. On Tuesday, February 20 MELTZER MARK J sold $2.52M worth of Intuitive Surgical, Inc. (NASDAQ:ISRG) or 6,000 shares. Samath Jamie also sold $485,202 worth of Intuitive Surgical, Inc. (NASDAQ:ISRG) on Friday, April 20. Brogna Salvatore sold $3.34M worth of Intuitive Surgical, Inc. (NASDAQ:ISRG) on Thursday, March 1.

Among 20 analysts covering Intuitive Surgical Inc (NASDAQ:ISRG), 14 have Buy rating, 1 Sell and 5 Hold. Therefore 70% are positive. Intuitive Surgical Inc had 77 analyst reports since July 22, 2015 according to SRatingsIntel. Morgan Stanley maintained Intuitive Surgical, Inc. (NASDAQ:ISRG) rating on Wednesday, April 18. Morgan Stanley has “Overweight” rating and $525 target. The rating was maintained by Wedbush with “Buy” on Tuesday, October 10. The firm earned “Overweight” rating on Tuesday, July 25 by Morgan Stanley. The stock of Intuitive Surgical, Inc. (NASDAQ:ISRG) earned “Buy” rating by Cantor Fitzgerald on Wednesday, January 10. The company was downgraded on Thursday, June 2 by Goldman Sachs. The firm has “Buy” rating given on Wednesday, July 22 by Canaccord Genuity. Wells Fargo maintained Intuitive Surgical, Inc. (NASDAQ:ISRG) rating on Monday, October 16. Wells Fargo has “Buy” rating and $413.0 target. The firm has “Hold” rating by RBC Capital Markets given on Wednesday, April 18. The rating was maintained by Goldman Sachs on Thursday, November 16 with “Buy”. Wedbush maintained the shares of ISRG in report on Sunday, September 6 with “Buy” rating.

Investors sentiment increased to 12.48 in 2017 Q4. Its up 11.44, from 1.04 in 2017Q3. It improved, as 23 investors sold ISRG shares while 21 reduced holdings. 91 funds opened positions while 458 raised stakes. 191.92 million shares or 430.23% more from 36.20 million shares in 2017Q3 were reported. Sio Management Lc holds 0.62% or 3,000 shares in its portfolio. Johnson Counsel Incorporated holds 4,290 shares or 0.04% of its portfolio. Fayez Sarofim & Com holds 128,325 shares or 0.24% of its portfolio. Savant Capital Ltd Llc has 0.05% invested in Intuitive Surgical, Inc. (NASDAQ:ISRG). Livforsakringsbolaget Skandia Omsesidigt holds 0.06% or 1,727 shares. Vantage Inv Advisors Ltd Liability accumulated 91 shares. Tower Rech (Trc) owns 1,885 shares or 0.09% of their US portfolio. Advantus Cap Management reported 11,595 shares. One National Association holds 0.51% in Intuitive Surgical, Inc. (NASDAQ:ISRG) or 20,690 shares. Sumitomo Mitsui Trust Hldgs holds 421,080 shares or 0.2% of its portfolio. Goldman Sachs Grp holds 832,200 shares. Meeder Asset Mngmt Incorporated owns 12,049 shares for 0.37% of their portfolio. Great West Life Assurance Company Can reported 228,441 shares. Pub Employees Retirement Association Of Colorado holds 0.05% of its portfolio in Intuitive Surgical, Inc. (NASDAQ:ISRG) for 20,861 shares. Pennsylvania Tru holds 1,605 shares or 0.03% of its portfolio.

Intuitive Surgical, Inc. (NASDAQ:ISRG) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>